Arcadia Biosciences, Inc.

RKDA Consumer Defensive Packaged Foods

Arcadia Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.9 million, down 3.71% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 35.9% and free cash flow grew 82.1%, each against the same quarter a year earlier.

0.16 0.04 −20.00%
Market cap
$490.0K
P/E
0.0×
Fwd P/E
−1.5×
Dividend yield
—
F-score
3/9
Altman Z
−59.20
Beneish M
−1.84
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
3 3 2 4 2 4 1 2 5 4
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
(59.20) (28.14) (19.08) (12.46) (7.86) (5.54) (9.13) (11.02) (15.07) (3.03)
P/S ratio
0.56 1.60 0.81 0.90 3.26 3.14 29.83 8.16 2.89 12.53
Altman Z″-Score (non-manufacturers)
(136.50) (64.94) (41.36) (24.78) (15.14) (11.29) (19.79) (22.31) (33.17) (4.57)
P/FCF ratio
2.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(3.15) (3.65) (0.87) (2.85) (3.32) (3.73) (6.96) (4.43) (4.34) (9.34)
Beneish M-Score
(1.84) 0.68 (0.63) (3.57) — 5.55 (0.32) (3.67) (1.79) (3.42)
P/B ratio
0.65 1.30 0.28 0.32 0.71 0.88 4.19 0.93 1.45 1.80
Price to Tangible BV
0.66 1.30 0.28 0.32 0.72 0.91 4.19 0.93 1.45 1.80
EV/Sales
(0.36) 0.78 (1.78) (1.86) (0.95) 0.35 8.28 7.64 4.89 4.56
EV/EBITDA
0.72 0.00 1.55 1.13 0.23 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
0.37 (0.41) 0.52 0.99 0.25 (0.09) (0.56) (0.82) (1.41) (0.85)
EV/FCF
(1.61) (0.42) 0.52 1.05 0.24 (0.09) (0.52) (0.81) (1.40) (0.84)
Quick Ratio
2.42 2.11 3.38 5.19 5.96 4.29 4.54 7.20 4.04 16.33
Current Ratio
3.09 3.61 4.17 6.03 7.02 5.02 4.98 7.49 4.27 16.69
Net Debt/EBITDA
1.89 1.40 2.27 1.69 1.02 2.02 1.35 1.29 0.92 1.40
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 6.86% 0.40% 0.00% 0.00% 44.41%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.11 0.02 0.00 0.00 1.13
Asset Turnover
0.48 0.30 0.18 0.20 0.15 0.20 0.04 0.07 0.11 0.05
Operating CF/Net income
2.03 1.37 1.09 0.91 1.76 6.49 0.60 1.01 0.89 0.87
Capex/Depreciation
8.82 7.10 0.11 0.48 (0.14) (1.40) (2.02) 6.15 (0.39) (0.52)
Interest Coverage
— — — 48.47 (1,776.30) (271.87) (3,876.20) — (19.16) (14.12)
ROE
(45.14%) (74.37%) (83.21%) (59.03%) (49.07%) (25.25%) (272.50%) (129.48%) (104.00%) (62.87%)
ROA
(23.32%) (42.37%) (57.50%) (42.22%) (32.13%) (11.65%) (101.79%) (66.41%) (42.95%) (30.00%)
ROIC
0.00% (115.09%) (359.45%) (3,419.68%) (884.26%) (130.26%) 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(54.33%) (104.73%) (122.08%) (70.31%) (44.92%) (16.10%) (117.42%) (66.68%) (132.87%) (39.56%)
Average Days of Receivables
31.93 85.01 41.47 60.08 73.75 63.88 187.96 41.89 111.97 61.02
Research and Development Expense of Revenue
0.19% 1.05% 1.44% 20.34% 57.36% 99.08% 607.19% 414.55% 183.98% 271.74%
Selling, General and Administrative Expense of Revenue
144.11% 191.10% 184.87% 202.70% 338.32% 204.97% 1,160.56% 792.62% 264.56% 384.25%
Intangible Assets out of Total Assets
0.01 0.00 0.00 0.00 0.01 0.02 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
4.82% 10.15% 16.10% 14.91% 22.73% 25.42% 195.64% 105.87% 36.61% 33.22%
Graham Net Nets
1.46 0.24 2.21 2.59 1.02 0.51 0.12 0.98 0.56 0.45
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(86.36%) (87.18%) (489.35%) (231.34%) (62.50%) (17.79%) (83.21%) (192.11%) (136.85%) (48.89%)
Free Cash Flow Yield
39.84% (115.37%) (421.82%) (195.70%) (121.35%) (129.15%) (53.50%) (116.13%) (120.59%) (43.26%)
Revenue per Share
3.55 3.70 3.60 12.38 12.74 32.27 7.35 15.54 74.69 57.44
Operating CF per Share
(3.46) (7.06) (12.36) (23.33) (48.62) (121.36) (108.10) (144.70) (259.09) (307.30)
Capex per Share
0.55 3.17 0.09 1.42 (1.86) (9.35) (9.18) (2.55) (1.39) (4.16)
Free Cash Flow per Share
(2.92) (3.90) (12.27) (21.92) (50.48) (130.70) (117.28) (147.25) (260.48) (311.46)
Cash per Share
3.34 3.11 9.41 34.46 53.92 103.08 159.22 231.67 241.61 910.99
Shareholders Equity per Share
3.03 4.57 10.27 34.89 58.64 114.67 52.33 136.04 148.55 399.96
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
3.03 4.57 10.27 34.89 58.64 114.67 52.33 136.04 148.55 399.96
Free Cash Flow
(3.99) (5.31) (15.18) (13.13) (26.86) (32.54) (18.66) (13.87) (14.04) (17.29)
Working Capital
4.30 6.68 11.38 21.19 30.35 25.38 22.73 19.82 11.52 49.09
Capital Expenditures
0.75 4.32 0.11 0.85 (0.99) (2.33) (1.46) (0.24) (0.07) (0.23)
Net Current Asset Value
3.95 1.95 7.97 17.38 22.67 12.90 4.19 11.67 6.48 17.85
EV/EBIT
0.70 0.00 1.30 0.99 0.18 0.00 0.00 0.00 0.00 0.00
Capex to Sales
(0.15) (0.86) (0.02) (0.11) 0.15 0.29 1.25 0.16 0.02 0.07
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
10.63 14.83 14.06 2.60 3.17 0.47 0.40 (0.10) 0.64 0.87
Cash ROIC
(45.83%) (50.73%) (62.37%) (31.60%) (44.85%) (56.63%) (55.22%) (40.05%) (66.76%) (17.66%)
Accounts Receivable Turnover
6.07 6.00 5.16 5.73 4.88 8.00 3.04 2.09 4.55 4.83
Accounts Payable Turnover
1.59 1.47 0.91 1.88 2.25 1.18 0.24 0.26 0.12 0.37
Inventory Turnover
2.93 3.40 1.38 1.81 2.11 1.85 0.90 3.22 1.18 3.28
Average Days of Payables
210.78 259.68 320.68 170.80 152.49 288.19 1,932.23 1,460.55 3,219.22 962.05
Days of Inventory on Hand
142.80 111.36 140.53 138.86 185.81 267.62 739.90 99.95 295.35 102.77
Average Receivables
0.80 0.84 0.86 1.30 1.39 1.00 0.39 0.70 0.88 0.66
Average Payables
1.95 2.01 2.38 3.25 3.87 4.40 3.67 2.57 2.43 2.39
Average Inventory
1.06 0.87 1.58 3.38 4.12 2.80 0.99 0.21 0.24 0.27
Average Assets
10.03 16.61 24.31 36.42 45.63 39.96 28.30 20.30 36.57 65.41
Average Common Equity
5.18 9.46 16.80 26.05 29.87 18.44 10.57 10.41 15.10 31.21

Fold the line items

Columns are period end dates